Molecular Recognition in Purinergic Receptors. 2
J ournal of Medicinal Chemistry, 2004, Vol. 47, No. 18 4415
(13) (a) Altona, C.; and Sundaralingam, M. Conformational Analysis
of the Sugar Ring in Nucleosides and Nucleotides. New Descrip-
tion Using the Concept of Pseudorotation. J . Am. Chem. Soc.
1972, 94, 8205-8212. (b) Altona, C.; Sundaralingam, M. Con-
formational Analysis of the Sugar Ring in Nucleosides and
Nucleotides. Improved Method for the Interpretation of Proton
Magnetic Resonance Coupling Constants. J . Am. Chem. Soc.
1973, 95, 2333-2344.
for Medicinal Chemistry. D.T.M. acknowledges the
financial support provided by the Israeli Ministry of
Science.
Su p p or tin g In for m a tion Ava ila ble: Figures related to
the CHARMM force field development and the partial atomic
charges developed for derivatives 2-12 are provided. This
material is available free of charge via the Internet at http://
pubs.acs.org.
(14) Davies, D. B.; Danyluk, S. S. International Symposiuym on NMR
Spectroscopy, University of Surrey, 1972.
(15) Blackburn, B. J .; Grey, A. A.; Smith, I. C. P.; Hruska, F. E.
Determination of the Molecular Conformation of Uridine in
Aqueous Solution by Proton Magnetic Resonance Spectroscopy.
Comparison with â-Pseudouridine. Can. J . Chem. 1970, 48,
2866-2870.
Refer en ces
(1) (a) Fischer, B. Therapeutic Applications of ATP-(P2)-Receptors
Agonists and Antagonists. Exp. Opin. Therap. Pat. 1999, 9, 385-
399. (b) Guile, S. D.; Ince, F.; Ingall, A. H.; Kindon, N. D.;
Meghani, P.; Mortimore, M. P. The Medicinal Chemistry of the
P2 Receptor Family. Prog. Med. Chem. 2001, 38, 115-187. (c)
Halbfinger, E.; Major, D. T.; Ritzmann, M.; Ubl, J .; Reiser, G.;
Boyer, J . L.; Harden, K. T.; Fischer, B. Molecular Recognition
of Modified Adenine Nucleotides by the P2Y1-Receptor. 1. A
Synthetic, Biochemical, and NMR Approach. J . Med. Chem.
1999, 42, 5325-5337. (d) Major, D. T.; Halbfinger, E.; Fischer,
B. Molecular Recognition of Modified Adenine Nucleotides by
the P2Y1-Receptor. 2. A Computational Approach. J . Med. Chem.
1999, 42, 5338-5347. (e) Major, D. T.; Laxer, A.; Fischer, B.
Protonation Studies of Modified Adenine and Adenine Nucle-
otides by Theoretical Calculations and 15N NMR. J . Org. Chem.
2002, 67, 790-802.
(2) (a) J acobson, K. A.; J arvis, M. F.; Williams, M.Purine and
Pyrimidine (P2) Receptors as Drug Targets J . Med. Chem. 2002,
45, 4057-4093. (b) van Rhee, A. M.; Fischer, B.; van Galen, P.
J . M.; J acobson, K. A. Modelling the P2Y Purinoceptor Using
Rhodopsin As Template. Drug Des. Discovery 1995, 13, 133-
154. (c) Moro, S.; Guo, D.; Camaioni, E.; Boyer, J . L.; Harden,
T. K.; J acobson, K. A Human P2Y(1) Receptor: Molecular
Modeling and Site-Directed Mutagenesis as Tools to Identify
Agonist and Antagonist Rrecognition Sites. J . Med. Chem. 1998,
41, 1456-1466. (d) Moro, S.; Hoffmann, C.; J acobson, K. A. Role
of the Extracellular Loops of G Protein-Coupled Receptors in
Ligand Recognition: A Molecular Modeling Study of the Human
P2Y(1) Receptor. Biochemistry 1999, 38, 3498-3509. (e) Kim,
H. O.; Barak, D.; Harden, T. K.; Boyer, J . L.; J acobson, K. A.
Acyclic and Cyclopropyl Analogues of Adenosine Bisphosphate
Antagonists of the P2Y(1) Receptor: Structure-Activity Rela-
tionships and Receptor Docking. J . Med. Chem. 2001, 44, 3092-
3108.
(3) Nahum, V.; Zu¨ndorf, G.; Le´vesque, S. A.; Beaudoin, A. R.; Reiser,
G.; Fischer B. Adenosine 5′-O-(1-Boranotriphosphate) Deriva-
tives as Novel P2Y1 Receptor Agonists. J . Med. Chem. 2002, 45,
5384-5396.
(4) Major, D. T.; Fischer, B. Molecular Recognition in Purinergic
Receptors. 1. A Comprehensive Computational Study of the
h-P2Y1-Receptor. J . Med. Chem. 2004, 47, 4391-4404.
(5) (a) Eckstein, F. Nucleoside Phosphorothioates. Annu. Rev.
Biochem. 1985, 54, 367-402. (b) Garcia, G. A.; Leatherbarrow,
R. J .; Eckstein, F.; Fersht, A. R. Metal-Ion Dependence of
Phosphorothioate ATP Analogues in the Bacillus-Stearother-
mophilus Tyrosyl-Transfer RNA-Synthetase Reaction. Biochem-
istry 1990, 29, 1643-1648.
(6) Fischer, B.; Chulkin, A.; Boyer, J . L.; Harden, T. K.; Gendron,
F.-P.; Beaudoin, A. R.; Chapal, J .; Hillaire-Buys, D.; Petit, P.
2-Thioether-5′-O-(1-thiotriphosphate) Adenosine Derivatives as
New Insulin Secretagogues Acting Through P2Y-receptors. J .
Med. Chem. 1999, 42, 3636-3646.
(7) Tulapurkar, M. E.; Laubinger, W.; Nahum, V.; Fischer, B.;
Reiser, G. Subtype Specific Internalization of P2Y1 and P2Y2
Receptors Induced by Novel Adenosine 5′-O-(1-boranotriphos-
phate) Derivatives. Br. J . Pharmacol. 2004, 142, 869-878.
(8) Saenger W. In Principles of nucleic acid structure; Springer-
Verlag: New York, 1984; pp 81-82.
(16) Hruska, F. E. In Conformations of Biological Molecules and
Polymers (Proceedings of J erusalem Symposium); Bergmann, E.
D., Pullman, B., Eds.; Israel Academy of Science and Humani-
ties: J erusalem, 1973; p 345.
(17) Nahum, V. and Fischer, B. Eur J . Inorg. Chem. 2004, in press.
(18) Fujii, A.; Patwari, G. N.; Ebata, T.; Mikami, N. Vibrational
Spectroscopic Evidence of Unconventional Hydrogen Bonds. Int.
J . Mass Spect. 2002, 220, 289-312.
(19) Srivastava, P. C.; Robins, R. K.; Meyer, R. B., J r. In Chemistry
of nucleosides and nucleotides; Townsend, L. B., Ed.; Plenum
Press: New York, 1988; Vol. 1, pp 197-198.
(20) Platts, J . A.; Howard, S. T.; Bracke, B. R. F. Directionality of
Hydrogen Bonds to Sulfur and Oxygen. J . Am. Chem. Soc. 1996,
118, 2726-2733.
(21) Meyer, P.; Schneider, B.; Sarfati, S.; Deville-Bonne, D.; Guer-
reiro, C.; Boretto, J .; Canard, B. Structural Basis for Activation
of R-Boranophosphate Nucleotide Analogues Targeting Drug-
resistant Reverse Transcriptase. EMBO J . 2000, 19, 3520-3529.
(22) J affe, E. K.; Cohn M. Divalent Cation-Dependent Stereospecifity
of Adenosine 5′-O-(2-thiotriphosphate) in the Hexokinase and
Pyrivate Kinase Reactions. The Absolute Stereochemistry of the
Diastereoisomers of Adenosine 5′-O-(2-thiotriphosphate). J . Biol.
Chem. 1978, 253, 4823-4825.
(23) J affe, E. K.; Cohn, M. 31P Nuclear Magnetic Resonance Spectra
of the Thiophosphate Analogues of Adenine Nucleotides; Effects
of pH and Mg2+ Binding. J . Biol. Chem. 1978, 17, 652-657.
(24) Romaniuk, P. J .; Eckstein, F. Structure of the Metal-Nucleotide
Complex in the Acetate Kinase Reaction. A Study with gamma-
32P-labled Phosphorothioate analogues of ATP. J . Biol. Chem.
1981, 256, 7322-7328.
(25) Lippard, S. J .; Berg, J . M. In Principles of Bioinorganic Chem-
istry, University Science Books: Mill Valley, CA, 1994; pp 64-
66, 132-133, 276-277.
(26) Klevickis & Grisham In Metal ion in biological systems; Sigel,
A., Sigel, H., Eds.; Marcel Dekker: New York, 1996; Vol. 32.
(27) (a) Lane, M.; Boatman, D. E.; Albrecht, R. M.; Bavister, B. D.
Intracellular Divalent Cation Homeostasis and Developmental
Competence in the Hamster Preimplantation Embryo. Mol.
Reprod. Dev. 1998, 50, 443-50. (b) Touyz, R. M.; Yao, G.
Modulation of Vascular Smooth Muscle Cell Growth by Magne-
sium-role of Mitogen-Activated Protein Kinases. J . Cell Physiol.
2003, 197, 326-335. (c) Grubbs, R. D. Intracellular Magnesium
and Magnesium Buffering. BioMetals 2002, 15, 251-259.
(28) Cohn, M. In Biological actions of extracellular ATP; Dubyak, G.
R., Fedan, J . S., Eds.; Annals of the New York Academy of
Sciences, Vol. 603; The New York Academy of Sciences: New
York, 1990.
(29) Macfarlane, D. E. 2-Methylthioadenosine [â-32P]diphosphate:
Synthesis and Use as Probe of Platelet ADP Receptors. Methods
Enzymol. 1992, 215, 137-142.
(30) (a) Kikugawa, K.; Suehiro, H.; Inchino, M. Platelet Aggregation
Inhibitors. 6. 2-Thioadenosine Derivatives. J . Med. Chem. 1973,
16, 1381-1388. (b) Kikugawa, K.; Suehiro, H.; Yanase, R.; Aoki,
A. Platelet Aggregation Inhibitors. IX. Chemical Transformation
of Adenosine into 2-Thioadenosine Derivatives. Chem. Pharm.
Bull. 1977, 25, 1959-1969.
(31) Vo¨hringer C, Scha¨fer R, Reiser G. A Chimeric Rat brain P2Y1
Receptor Tagged with Green-Fluorescent Protein: High-Affinity
Ligand Recognition of Adenosine Diphosphates and Triphos-
phates and Selectivity Identical to that of the Wild-Type Recep-
tor. Biochem. Pharmacol. 2000, 59, 791-800.
(32) Zu¨ndorf, G.; Scha¨fer, R.; Vo¨hringer, C.; Halbfinger, E.; Fischer,
B.; Reiser, G. Novel Modified Adenosine 5′-Triphosphate Ana-
logues Pharmacologically Characterized in Human Embryonic
Kidney 293 Cells Highly Expressing Rat Brain P2Y1 Receptor:
Biotinylated Analogue Potentially Suitable for Specific P2Y1
Receptor Isolation. Biochem. Pharmacol. 2001, 61, 1259-1269.
(33) Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J .;
Swaminathan, S.; Karplus, M. CHARMM. A program for mac-
romolecular energy, minimization, and dynamics calculations.
J . Comput. Chem. 1983, 4, 187-217.
(9) Donohue, J .; Trueblood, K. N. Base Pairing in DNA. J . Mol. Biol.
1960, 2, 363-371.
(10) Sundaralingam, M. Stereochemistry of Nucleic Acids and their
Constituents. IV. Allowed and Preferred Conformations of
Nucleosides, Nucleoside Mono-, Di-, Tri-, Tetraphosphates,
Nucleic Acids, and Polynucleotides. Biopolymers 1969, 7, 821-
860.
(11) Ippel, J . H.; Wijmenga, S. S.; de J ong, R.; Heus, H. A.; Hilbers,
C. W. Heteronuclear Scalar Coupling in the Bases and Sugar
Rings of Nucleic Acids: Their Determination and Application
in Assignment and Conformational Analysis. Magn. Reson.
Chem. 1996, 34, S156-S176.
(12) Davies, D. B.; Danyluk, S. S. Nuclear Magnetic Resonance
Studies of 5′-Ribo- and Deoxyribonucleotide Structures in Solu-
tion. Biochemistry 1974, 13, 4417-4434.